Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$903K Buy
287,631
+8,878
+3% +$27.8K 0.01% 1028
2026
Q1
$814K Buy
278,753
+37,771
+16% +$108K 0.01% 973
2025
Q4
$595K Buy
240,982
+81,905
+51% +$195K 0.01% 1072
2025
Q3
$355K Buy
159,077
+115,636
+266% +$265K ﹤0.01% 1329
2025
Q2
$105K Sell
43,441
-159,806
-79% -$389K ﹤0.01% 1564
2025
Q1
$474K Buy
203,247
+160,373
+374% +$321K 0.01% 1065
2024
Q4
$79.3K Sell
42,874
-28,520
-40% -$63.1K ﹤0.01% 1413
2024
Q3
$174K Buy
71,394
+14,812
+26% +$33.2K ﹤0.01% 1339
2024
Q2
$116K Buy
56,582
+936
+2% +$2.13K ﹤0.01% 1345
2024
Q1
$138K Buy
55,646
+13,407
+32% +$34.9K ﹤0.01% 1263
2023
Q4
$118K Buy
42,239
+21,675
+105% +$58.5K ﹤0.01% 1268
2023
Q3
$53.1K Buy
+20,564
New +$59.5K ﹤0.01% 1231

Other funds holding ABEV

Vident Advisory's ABEV Position: Q2 2026 in Review

Vident Advisory increased its Ambev (ABEV) stake by 3.2% in Q2 2026, buying an estimated $27.8K and bringing the position to 287,631 shares worth $903K. The position accounts for 0.01% of the portfolio, ranked #1028.

Vident Advisory first reported a position in ABEV in Q3 2023 and has held it in 12 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Vident Advisory held 287,631 shares of Ambev worth $903K as of Q2 2026.
  • Vident Advisory bought 8,878 Ambev shares in Q2 2026, an estimated $27.8K.
  • Ambev made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1028 holding.
  • Vident Advisory first reported a position in Ambev in Q3 2023 and has held it in 12 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.